51 – 60 of 250
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
- Contribution to journal › Article
- 2022
-
Mark
Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer
- Contribution to journal › Article
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
- Contribution to journal › Article
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
- Contribution to journal › Article
-
Mark
Incidence and trends of basal cell carcinoma in Sweden : A population-based registry study
- Contribution to journal › Article
-
Mark
Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study
- Contribution to journal › Article
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
- Contribution to journal › Scientific review
